Progyny, Inc.

PGNY·NasdaqGS·Healthcare
Compare
34.10+4.00 (+13.29%)today
As of Nov 5, 10:17 AM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close30.10
Open33.17
Day range32.0335.50
52-week range16.1035.50
Off day high−3.94%
Off 52-week high−3.94%
Volume350.56K
Avg. volume (3M)1.12M
Market cap2.62B
EPS (TTM)0.9200
Forward P/E14.74
P/E ratio (TTM)37.07
Dividend yield—
Beta (5Y)0.95
Shares outstanding76.73M
Short interest8.93% of float
Earnings dateNov 4, 2026
Analyst target34.42
Profit margin6.00%

Against its peers

Compare in full ›
PGNY ELV MD PRVA 3NX.F AVAH
Market cap 2.62B 96.81B 2.59B 2.96B 629.56M 3.13B
P/E (TTM) 37.1 19.0 18.1 110.3 25.2 11.4
Forward P/E 14.7 14.7 13.4 21.8 — 15.8
Price/book 5.5 2.2 3.0 3.7 0.6 10.9
Dividend yield — 1.58% — — 1.88% —
1-year change +67.13% +38.08% +50.32% −6.59% −1.56% +64.89%
Today +13.29% +2.81% +1.04% +3.44% 0.00% +0.77%

The closest companies by business and industry (Healthcare Plans). Prices may be delayed up to 15 min.

Latest news

All PGNY news ›
BBC News·Negative

Women welcome annual check for debilitating condition

Neelam Heera-Shergill founded charity Cysters to provide support she felt was missing after her diagnosis When Neelam Heera-Shergill was diagnosed with polycystic ovary syndrome (PCOS) at the age of 18, she feared it could one day stop her…

markets.businessinsider.com·Negative

Leerink Partners Sticks to Its Buy Rating for Progyny (PGNY)

In a report released today, Michael Cherny from Leerink Partners reiterated a Buy rating on Progyny, with a price target of $37.00. According to TipRanks, Cherny is a 4-star analyst with an average return of 5.5% and a 57.42% success rate.…

From the 4Search news index, newest first.

In the news

15mentions in 30 days
15with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 15 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance